Ligand validation:6TD2

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6TD2_EDO_A_606	71%	60%	0.106	0.927	0.74	0.75	-	-	0	0	100%	1
6TD2_EDO_B_603	49%	65%	0.179	0.926	0.75	0.59	-	-	1	0	100%	1
6TD2_EDO_A_604	34%	63%	0.213	0.897	0.7	0.69	-	-	0	0	100%	1
6TD2_EDO_A_605	33%	65%	0.227	0.907	0.73	0.58	-	-	0	0	100%	1
6TD2_EDO_B_604	29%	62%	0.213	0.871	0.73	0.7	-	-	0	0	100%	1
6TD2_EDO_B_602	3%	63%	0.347	0.691	0.75	0.66	-	-	0	0	100%	1
7R02_EDO_A_609	0%	85%	0.353	0.338	0.5	0.25	-	-	1	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
7CJO_EDO_B_1210	100%	83%	0.038	0.99	0.47	0.32	-	-	0	0	100%	1
4O78_EDO_A_202	100%	86%	0.043	0.992	0.4	0.33	-	-	0	0	100%	1
6QRS_EDO_A_401	100%	83%	0.045	0.991	0.47	0.31	-	-	0	0	100%	1
1EB6_EDO_A_1180	100%	64%	0.041	0.986	0.62	0.72	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.